Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

Now, researchers in a lab at the University of Minnesota, using a drug called CD200AR-L, have developed their own vaccine to ...

Children’s Minnesota is testing the safety of a new vaccine combination to combat one of the deadliest pediatric cancers, which could give new hope for children who would otherwise typically die ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines ...

The trial consisted of four cohorts with increasing doses of peptide vaccines ranging from 0.5 to 3.0 mg. Eligible patients received three inoculations 3 weeks apart. A total of 24 patients (six ...

(10) By detailing their synthesis, hybridization strategies ... from drug delivery and biocatalysis to vaccines. Collectively, these Accounts illustrate how chemical design underpins innovation in ...

Cell penetrating peptides (CPPs) are usually positive charged peptides and have good cell membrane permeability. Meanwhile, CPPs are facile to synthesize, and can be functionalized to satisfy ...